Remove Clinic Remove Clinical Practice Remove Lab Testing Remove Medical
article thumbnail

Outcomes of Guidelines from Health Technology Assessment Organizations: A Systematic Mixed Studies Review [Systematic review, meta-analysis, or scoping review]

Annals of Family Medicine

Context: Health Technology Assessment (HTA) organizations determine the value of health technologies such as medical devices, lab tests, or medications. learning), the use of guideline-based information in clinical practice, and subsequent patient health outcomes. Health organization outcomes.

article thumbnail

Working Out – Dan Minter

The Clinical Problem Solvers

If you’re anything like me, you’ve probably found yourself asking that question after listening to a discussant on the podcast arrive at some unexpected diagnosis, only to have the biopsy or lab test prove them right. These clinicians recount rigorous efforts directed towards improving their knowledge and clinical skills.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Incredible Shrinking Exemption: FDA Final CDS Guidance Would Significantly Narrow the Scope of Exempt Clinical Decision Support Software Under the Cures Act

FDA Law Blog

Javitt — On September 28, 2022, the FDA issued the long anticipated final Clinical Decision Support Software Guidance (CDS Guidance), which replaces the revised draft guidance document from 2019. Criterion 2 : Non-Device CDS software functions display, analyze or print medical information about a patient or other medical information.

Clinic 52
article thumbnail

How to Make an Alzheimer’s Diagnosis in Primary Care: A Podcast with Nathaniel Chin

GeriPal

We now have biomarkers that can reasonably approximate the degree of amyloid build-up in the brain with a simple blood test. We have two new FDA-approved medications that reduce that amyloid buildup and modestly slow down the progression of the disease. Summary Transcript CME Summary Things are changing quickly in the Alzheimers space.

article thumbnail

What can we learn from simulations? Amber Barnato

GeriPal

Amber tells the moving story of how these findings led a clinical colleague, her chief, to question and change his behavior. Alex: We are delighted to welcome Amber Barnato, who’s a palliative care physician and health service researcher, and she’s director of the Dartmouth Institute for Health Policy and Clinical Practice.